| °Ë»ö°á°ú: | ÃÑ 16697°³ Áß 15731 - 15740 | Á¤·Ä±âÁØ: |
Q&A
¾Æ¸ð¶ó´Ðµà¿À¿¡ ´ëÇØ
µ¿½ÅÁ¦¾à¿¡¼ ¸¸µç ¾Æ¸ð¶ó´Ðµà¿À¿¡ °üÇÑ Á¤º¸¸¦ ¿Ã·ÁÁÖ½Ã¸é °í¸¿°Ú½À´Ï´Ù.
ÀÛ¼ºÀÏ 2002.05.03 - ´äº¯¼ö 0 - Ãßõ¼ö 1 - Á¶È¸¼ö 607
À¯³ë°ñ,¶óÀÌ»çÀÇ º¸Çè±Þ¿©±âÁØ
[´äº¯] º¸°Çº¹ÁöºÎ°í½ÃÁ¦2001-28È£¿¡ ÀÇÇϸé dihydroergocristine mesylate°æ±¸Á¦(ǰ¸í: À¯³ë°ñÁ¤ µî)ÀÇ ±Þ¿©±âÁØÀº...
ÀÛ¼ºÀÏ 2002.05.03 - ´äº¯¼ö 0 - Ãßõ¼ö 1 - Á¶È¸¼ö 639
ºñŸ¹ÎEÀÇ ÁÖÀÇ»çÇ×
[´äº¯] Clinical pharmacologyÀÇ Á¤º¸¿¡ ÀÇÇÏ¸é ºñŸ¹Î K°áÇÌ¿¡ ÀÇÇÑ ÀúÇÁ·ÎÆ®·ÒºóÇ÷Áõ (Hypoprothrombinemia)...
ÀÛ¼ºÀÏ 2002.05.03 - ´äº¯¼ö 0 - Ãßõ¼ö 1 - Á¶È¸¼ö 950
±Þ¿©µÇ´Â ¾à¹°¿¡´ëÇØ
º¸Çè±Þ¿©°¡µÇ°Å³ª ºüÁö´Â ¾à¹°À»
bit program¿¡ Àû¿ëÇÒ¼ö ÀÖµµ·Ï ºÎʵ右´Ï´Ù
º¸Çè°¡ º¯µ¿ºÐµµ ºÎʵ右´Ï´Ù....
ÀÛ¼ºÀÏ 2002.05.02 - ´äº¯¼ö 1 - Ãßõ¼ö 1 - Á¶È¸¼ö 281
º¸³ª¸µ¿¡ÀÌ...
º¸³ª¸µ¿¡ÀÌ ¸ð¾çÀÌ º¯°æµÈ °ÍÀ¸·Î ¾Ë°í ÀÖ½À´Ï´Ù. Á¤Á¦ ¾ÈÀÇ ¿µ¹®ÀÚ°¡ ¹Ù²ï °ÍÀ¸·Î ¾Ë°í Àִµ¥, »õ·Î¿î ¸ð¾çÀ¸·Î ¹Ù²ï »çÁøÀ» ¿Ã·Á ÁÖ¾úÀ¸¸é...
ÀÛ¼ºÀÏ 2002.05.02 - ´äº¯¼ö 0 - Ãßõ¼ö 1 - Á¶È¸¼ö 1217
ºñ±³¿ëÃâ..»ýµ¿¼º..
º´¿øÃ³¹æ¿¡ ºñ±³¿ëÃâ½ÃÇèÀ̳ª »ýµ¿¼º½ÃÇèÀ» °ÅÄ¡Áö ¾ÊÀº ǰ¸ñ ÀÌ Ã³¹æ¾àÀ¸·Î ³ª¿ÔÀ»¶§~~~~~~>¾à»ç°¡ ºñ±³¿ëÃâ½ÃÇèÀ̳ª »ýµ¿¼º½ÃÇèÀ» °ÅÄ£ µ¿ÀÏ ¼º...
ÀÛ¼ºÀÏ 2002.05.02 - ´äº¯¼ö 0 - Ãßõ¼ö 1 - Á¶È¸¼ö 710
¶ôŸ¸ñ½º½Ã·´ Ãß°¡ÇÏ¿´½À´Ï´Ù
[´äº¯] "¶ôŸ¸ñ½º"·Î °Ë»öÇØº¸½Ã¸é ¶ôŸ¸ð½Ã½Ã·´¿¡ ´ëÇÑ ³»¿ëÀ» º¸½Ç ¼ö ÀÖ½À´Ï´Ù. °¨»çÇÕ´Ï´Ù. [¿øº»] ¾È³çÇϼ¼¿ä? ¶ôŸ¸ñ½º ½Ã·´ÀÌ Ã³¹æÀÌ...
ÀÛ¼ºÀÏ 2002.05.02 - ´äº¯¼ö 0 - Ãßõ¼ö 1 - Á¶È¸¼ö 714
¾Æ´Þ¶óÆ® ¿À·Î½ºÁ¤ ¼öÁ¤
[´äº¯] ¾È³çÇϼ¼¿ä. ÇØ´çºÎºÐÀ» ¼öÁ¤ÇÏ¿´½À´Ï´Ù. ¸»¾¸ÇØÁּż Á¤¸» °¨»çµå¸®¸ç ´õ¿í Á¤È®ÇÑ Á¤º¸¸¦ À§ÇØ ³ë·ÂÇϰڽÀ´Ï´Ù. [¿øº»] ¾Æ´Þ¶ó...
ÀÛ¼ºÀÏ 2002.05.02 - ´äº¯¼ö 0 - Ãßõ¼ö 1 - Á¶È¸¼ö 693
ÆÄ¸ñ½Å½Ã·´...
[´äº¯] °Ô½Ã¹° ¹øÈ£1507¹øÀ» º¸½Ã¸é ¾ÆÀÌ·Î¼Õ ½Ã·´ÀÌ Æø¹ßÇß´Ù´Â ±Ûµµ ¿Ã¶ó¿Í ÀÖ½À´Ï´Ù. ´ä±ÛÀÎ 1513¹ø ±Ûµµ ÀÐÀ¸½Ã¸é µµ¿òÀÌ µÇ½Ç°Í °°½À...
ÀÛ¼ºÀÏ 2002.05.02 - ´äº¯¼ö 0 - Ãßõ¼ö 1 - Á¶È¸¼ö 703
¼öÁ¤ÇÏ¿´½À´Ï´Ù
[´äº¯] ¾È³çÇϼ¼¿ä. ÇØ´çºÎºÐÀ» Á¤Á¤ÇÏ¿´½À´Ï´Ù. È¥¶õÀ» µå·Á Á˼ÛÇÏ¸ç ´õ¿í Á¤È®ÇÑ Á¤º¸¸¦ À§ÇØ ³ë·ÂÇϰڽÀ´Ï´Ù. [¿øº»] ¾àǰ°Ë»ö½Ã ¶ôÅ׿Ã...
ÀÛ¼ºÀÏ 2002.05.02 - ´äº¯¼ö 0 - Ãßõ¼ö 1 - Á¶È¸¼ö 472
